INDO US BIOTECH
Quarterly Results Analysis [Sep2024]
INDO US BIOTECH Quarterly Results
Standalone | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 Audited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹22 Cr | ₹25 Cr | ₹16 Cr | ₹22 Cr | ₹16 Cr | ₹19 Cr | ₹18 Cr | ₹16 Cr |
Expenses | ₹17 Cr | ₹21 Cr | ₹15 Cr | ₹18 Cr | ₹13 Cr | ₹16 Cr | ₹15 Cr | ₹13 Cr |
Operating Income | ₹5 Cr | ₹4 Cr | ₹1 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr |
Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Profit Before Tax | ₹4 Cr | ₹3 Cr | ₹1 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr |
Profit After Tax | ₹4 Cr | ₹3 Cr | ₹1 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr |
EPS | ₹2.17 | ₹1.58 | ₹0.26 | ₹1.84 | ₹0.83 | ₹1.18 | ₹1.38 | ₹0.68 |
Industry Peers & Returns | 1W | 1M | 1Y |
INDO US BIOTECH | 2.4% | 9.4% | 9.8% |
BOMBAY BURMAH TRADING CORPORATION | -1.1% | -6.3% | 66.4% |
KAVERI SEED COMPANY | 0.4% | -2% | 39.6% |
VENKYS (INDIA) | 0% | 0.1% | -15.2% |
BOMBAY SUPER HYBRID SEEDS | -4.4% | -13.3% | -38% |
TIERRA AGROTECH | 6.5% | 3.3% | -36.9% |
NATH BIOGENES (INDIA) | 2.5% | -9.8% | -14.7% |
MANGALAM SEEDS | -7.4% | -13.4% | -10.8% |
SHREE OSWAL SEEDS AND CHEMICALS | -4.6% | -13.3% | -62.1% |
INDO US BIOTECH Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -10.30 % |
Y-o-Y | 40.21 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹22 Cr | -10.30 | |
Jun2024 | ₹25 Cr | 56.78 | |
Mar2024 | ₹16 Cr | -28.71 | |
Dec2023 | ₹22 Cr | 39.84 | |
Sep2023 | ₹16 Cr | -17.39 | |
Jun2023 | ₹19 Cr | 5.70 | |
Mar2023 | ₹18 Cr | 16.82 | |
Dec2022 | ₹16 Cr | - |
INDO US BIOTECH Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 38.77 % |
Y-o-Y | 97.46 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹5 Cr | 38.77 | |
Jun2024 | ₹4 Cr | 280.52 | |
Mar2024 | ₹1 Cr | -77.12 | |
Dec2023 | ₹4 Cr | 63.45 | |
Sep2023 | ₹3 Cr | -13.27 | |
Jun2023 | ₹3 Cr | -3.33 | |
Mar2023 | ₹3 Cr | 50.71 | |
Dec2022 | ₹2 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 54.72 % |
Y-o-Y | 40.85 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 23.1% | 54.72 | |
Jun2024 | 14.93% | 142.76 | |
Mar2024 | 6.15% | -67.92 | |
Dec2023 | 19.17% | 16.89 | |
Sep2023 | 16.4% | 4.99 | |
Jun2023 | 15.62% | -8.55 | |
Mar2023 | 17.08% | 29.00 | |
Dec2022 | 13.24% | - |
INDO US BIOTECH Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 37.58 % |
Y-o-Y | 161.08 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹4 Cr | 37.58 | |
Jun2024 | ₹3 Cr | 504.77 | |
Mar2024 | ₹1 Cr | -85.78 | |
Dec2023 | ₹4 Cr | 120.66 | |
Sep2023 | ₹2 Cr | -29.60 | |
Jun2023 | ₹2 Cr | -14.46 | |
Mar2023 | ₹3 Cr | 102.26 | |
Dec2022 | ₹1 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 53.35 % |
Y-o-Y | 86.17 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 19.66 % | 53.35 | |
Jun2024 | 12.82 % | 286.14 | |
Mar2024 | 3.32 % | -80.07 | |
Dec2023 | 16.66 % | 57.77 | |
Sep2023 | 10.56 % | -14.77 | |
Jun2023 | 12.39 % | -19.07 | |
Mar2023 | 15.31 % | 73.19 | |
Dec2022 | 8.84 % | - |
INDO US BIOTECH Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 37.34 % |
Y-o-Y | 161.45 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹2.17 | 37.34 | |
Jun2024 | ₹1.58 | 507.69 | |
Mar2024 | ₹0.26 | -85.87 | |
Dec2023 | ₹1.84 | 121.69 | |
Sep2023 | ₹0.83 | -29.66 | |
Jun2023 | ₹1.18 | -14.49 | |
Mar2023 | ₹1.38 | 102.94 | |
Dec2022 | ₹0.68 | - |
You may also like the below Video Courses
BOMBAY BURMAH TRADING CORPORATION LTD vs KAVERI SEED COMPANY LTD vs VENKYS (INDIA) LTD
BOMBAY SUPER HYBRID SEEDS LTD vs TIERRA AGROTECH LTD vs INDO US BIOTECH LTD